scispace - formally typeset
J

Jyoti Kureel

Researcher at Central Drug Research Institute

Publications -  13
Citations -  343

Jyoti Kureel is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Osteoblast & Ovariectomized rat. The author has an hindex of 8, co-authored 13 publications receiving 262 citations.

Papers
More filters
Journal ArticleDOI

miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation

TL;DR: It is shown that miR-542-3p, a well-characterized tumor suppressor whose downregulation is tightly associated with tumor progression via C-src-related oncogenic pathways, inhibits osteoblast proliferation and differentiation and inhibits BMP-7-mediated osteogenesis.
Journal ArticleDOI

IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation.

TL;DR: In this paper, the role of IL-18BP on osteoblasts was investigated in post menopausal osteoporosis, and the effect of humanized IL18BPd on various immune and skeletal parameters.
Journal ArticleDOI

Medicarpin, a Natural Pterocarpan, Heals Cortical Bone Defect by Activation of Notch and Wnt Canonical Signaling Pathways.

TL;DR: It was observed that med promoted bone regeneration by activating canonical Wnt and notch signaling pathway in cortical bone defect model that heals by intramembranous ossification, and confirmed that med treatment leads to elevated bone healing in pre-osteoblasts by co localization of beta catenin with osteoblast marker alkaline phosphatase.
Journal ArticleDOI

Synthesis, optical resolution, absolute configuration, and osteogenic activity of cis-pterocarpans

TL;DR: A comparative mechanism study for osteogenic (bone forming) activity of medicarpin revealed that (+)-(6aS,11aS)-medicarpin (6a) significantly increased the bone morphogenetic protein-2 expression and the level of the bone-specific transcription factor Runx-2 mRNA, while the effect was opposite for the other enantiomer.
Journal ArticleDOI

Identification of novel microRNA inhibiting actin cytoskeletal rearrangement thereby suppressing osteoblast differentiation

TL;DR: Overall, miR-1187 functions as a negative regulator of osteogenesis by repressing BMPR-II and ArhGEF-9 expression thus suppressing non-Smad BMP2/Cdc42 signaling pathway and inhibiting actin reorganization.